Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08) (English, HTML)

View metadata and access the original English HTML file: Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08).

Format

HTML

Access

file-only

Publisher-reported update

2023-10-01

The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination with another drug), etomidate, fedratinib, lefamulin, obiltoxaximab, polatuzumab vedotin, ripretinib, satralizumab and sonidegib to the Prescription Drug List (PDL) for human and/or veterinary use.

Access original file